Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of dexmedetomidine transdermal patch for perioperative analgesia
ChiCTR2300075419Phase 2Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: NRS pain intensity scale, Respiration and 1 more. Started Sep 2023; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300075419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075419.